Zoladex

Active Ingredient(s): Goserelin
FDA Approved: * December 29, 1989
Pharm Company: * ASTRAZENECA
Category: Cancer

Goserelin, sold under the brand name Zoladex among others, is a medication which is used to suppress production of the sex hormones (testosterone and estrogen), particularly in the treatment of breast and prostate cancer.[1][2] It is an injectable gonadotropin releasing hormone agonist (GnRH agonist). Structurally, it is a decapeptide. It is the natural GnRH decapeptide with two substitutions to inhibit rapid degradation. Goserelin stimulates the production of ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zoladex 3.6 mg/1 Subcutaneous Implant
NDC: 0310-0950
Labeler:
Astrazeneca Pharmaceuticals Lp
Zoladex 10.8 mg/1 Subcutaneous Implant
NDC: 0310-0951
Labeler:
Astrazeneca Pharmaceuticals Lp
Zoladex 3.6 mg Subcutaneous Implant
NDC: 50090-2027
Labeler:
A-s Medication Solutions
Zoladex 3.6 mg Subcutaneous Implant
NDC: 50090-3466
Labeler:
A-s Medication Solutions
Zoladex 3.6 mg Subcutaneous Implant
NDC: 70720-950
Labeler:
Tersera Therapeutics LLC
Zoladex 10.8 mg Subcutaneous Implant
NDC: 70720-951
Labeler:
Tersera Therapeutics LLC